ras p21 isoprenylation inhibition induces flat colon tumors in wistar rats

Diseases of the Colon and Rectum

Volumn 43, Issue 1, 2000, Pages 70-75

  Iishi, Hiroyasu ^a   Tatsuta, Masaharu ^a   Baba, Miyako ^a   Yano, Hiroyuki ^a   Sakai, Noriko ^a   Uehara, Hiroyuki ^a   Nakaizumi, Akihiko ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Azoxymethane; Colon carcinogenesis; Flat colon tumor; Pravastatin; Ras p21 isoprenylation; Rat

Indexed keywords

AZOXYMETHANE; CARCINOGEN; PRAVASTATIN; PROTEIN P21; RAS PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INCIDENCE; COLON CARCINOGENESIS; COLON TUMOR; CONTROLLED STUDY; DRUG EFFECT; GENE MUTATION; HISTOPATHOLOGY; ISOPRENYLATION; MALE; NONHUMAN; ONCOGENE K RAS; POINT MUTATION; RAT;

EID: 0033980025     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02237247     Document Type: Article

References (25)

1. Levin B, Raijman I. Malignant tumors of the colon and rectum. In: Haubrich WS, Schaffner F, Berk JE, eds. Bockus gastroenterology, 5th ed. Philadelphia: WB Saunders, 1995:1744-72.
2. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
3. Iishi H, Tatsuta M, Tsutsui S, et al. Early depressed adenocarcinomas of the large intestine. Cancer 1992;69: 2406-10.
4. Fujimori T, Satonaka K, Yamamura-Idei Y, Nagasako K, Maeda S. Non-involvement of ras mutations in flat colorectal adenomas and carcinomas. Int J Cancer 1994;57: 51-5.
5. Minamoto T, Sawaguchi K, Mai M, Yamashita N, Sugimura T, Esumi H. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res 1994;54:2841-4.
6. Egan SE, Weinberg RA. The pathway to signal achievement. Nature 1993;365:781-3.
7. McCormick F. How receptors turn RAS on. Nature 1993; 363:15-6.
8. Sinensky M, Beck LA, Leonard S, Evans R. Differential inhibitory effects of lovastatin on protein isoprenylation and sterol synthesis. J Biol Chem 1990;265:19937-41.
9. ras isoprenylation, of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats. Br J Cancer 1998;77:581-7.
10. Vivona AA, Shpitz B, Medline A, et al. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis 1993;14:1771-81.
11. Shivapurkar N, Tang Z, Ferreira A, Nasim S, Garett C, Alabaster O. Sequential analysis of K-ras mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in Fischer-344 rats on high-risk diet. Carcinogenesis 1994;15:775-8.
12. Singh J, Kulkarni N, Kelloff G, Reddy BS. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis. Carcinogenesis 1994;15:1317-23.
13. Rubio C, Shetye J. Flat adenoma-adenocarcinoma sequence in the colon of rats. Dis Colon Rectum 1994;37: 1300-6.
14. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982;218:474-5.
15. Morstyn, G, Hsu S-M, Kinsella T, Gratzner H, Russo A, Mitchell JB. Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest 1983;72:1844-50.
16. Törmänen U, Eerola A-K, Rainio P, et al. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 1995;55:5595-602.
17. Takahashi-Fujii A, Ishino Y, Shimada A, Kato I. Practical application of fluorescence-based image analyzer for PCR single-stranded conformation polymorphism analysis used in detection of multiple point mutations. PCR Methods Appl 1993;2:323-7.
18. Ura H, Obata T, Nishino N, Tanno S, Okumura K, Namiki M. Cytotoxicity of simvastatin to pancreatic adenocarcinoma cells containing mutant ras gene. Jpn J Cancer Res 1994;85:633-8.
19. Miller RG Jr. Simultaneous statistical inference. New York: McGraw-Hill, 1966.
20. Morris TJ, Palm SL, Furcht LL, Buchwald H. Effect of lovastatin alone and as an adjuvant chemotherapeutic agent on hepatoma tissue culture-4 cell growth. Ann Surg Oncol 1995;2:266-74.
21. Kawata S, Nagase T, Yamasaki E, Ishiguro H, Matsuzawa Y. Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2). Br J Cancer 1994;69: 1015-20.
22. Narisawa T, Fukaura Y, Terada K, et al. Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice. Carcinogenesis 1994;15:2045-8.
23. Tsujitani S, Shirai H, Tatebe S, et al. Apoptotic cell death and its relationship to carcinogenesis in colorectal carcinoma. Cancer 1996;77:1711-6.
24. Okuyama S, Yokota K, Yuki M. Cell proliferation and cell death (apoptosis) in epithelial tumors of the stomach - analysis of tumor tissues by the endoscopic mucosal resection. Jpn J Gastroenterol 1995;92:130-9.
25. Ura H, Ohara T, Takago Y. Farnesyl transferase inhibitors induces apoptosis in cultured pancreatic cell lines. J Jpn Soc Gastroenterol Carcinog 1997;9:67-8.